Clinical impact of peripheral attacks in hereditary angioedema patients.
暂无分享,去创建一个
A. Knulst | J. Nuijens | M. Cicardi | B. Zuraw | R. Levy | C. Hack | A. Relan | D. Moldovan | A. Kusuma | C. E. Hack | André C. Knulst | Jan H. Nuijens | C. Hack
[1] E. S. Amersfoort,et al. Recombinant C1-Inhibitor , 2012, BioDrugs.
[2] M. Cicardi,et al. Target levels of functional C1‐inhibitor in hereditary angioedema , 2012, Allergy.
[3] J. Nuijens,et al. Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema. , 2010, The Journal of allergy and clinical immunology.
[4] William H. Yang,et al. Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema. , 2010, The New England journal of medicine.
[5] Francesco Tedesco,et al. Novel pathogenic mechanism and therapeutic approaches to angioedema associated with C1 inhibitor deficiency. , 2009, The Journal of allergy and clinical immunology.
[6] T. Craig,et al. Frequency, timing, and type of prodromal symptoms associated with hereditary angioedema attacks. , 2009, Allergy and asthma proceedings.
[7] B. Zuraw. Clinical practice. Hereditary angioedema. , 2008, The New England journal of medicine.
[8] A. Tordai,et al. Mutation screening of C1 inhibitor gene in 108 unrelated families with hereditary angioedema: functional and structural correlates. , 2008, Molecular immunology.
[9] K. Bork,et al. Treatment of skin swellings with C1‐inhibitor concentrate in patients with hereditary angio‐oedema , 2008, Allergy.
[10] M. Frank. 8. Hereditary angioedema. , 2008, The Journal of allergy and clinical immunology.
[11] H. Farkas,et al. Recombinant human C1‐inhibitor in the treatment of acute angioedema attacks , 2007, Transfusion.
[12] K. Bork,et al. Hereditary angioedema: new findings concerning symptoms, affected organs, and course. , 2006, The American journal of medicine.
[13] K. Bork,et al. Treatment with C1 inhibitor concentrate in abdominal pain attacks of patients with hereditary angioedema , 2005, Transfusion.
[14] A. Eerenberg,et al. A phase I study of recombinant human C1 inhibitor in asymptomatic patients with hereditary angioedema. , 2005, The Journal of allergy and clinical immunology.
[15] B. Hoggart,et al. Pain: a review of three commonly used pain rating scales. , 2005, Journal of clinical nursing.
[16] M. Gompels,et al. C1 inhibitor deficiency: consensus document , 2005, Clinical and experimental immunology.
[17] A. Tordai,et al. Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond , 2004, Journal of Allergy and Clinical Immunology.
[18] M. Cicardi,et al. Bradykinin-mediated angioedema. , 2002, The New England journal of medicine.
[19] P. Bijur,et al. Reliability and validity of a visual analog scale for acute abdominal pain in the ED. , 2002, The American journal of emergency medicine.
[20] A. Davis,et al. Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor. , 2002, The Journal of clinical investigation.
[21] W. Tremaine,et al. Hereditary angioedema: a broad review for clinicians. , 2001, Archives of internal medicine.
[22] K. Bork,et al. Treatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedema. , 2001, Archives of internal medicine.
[23] K. Bork,et al. Asphyxiation by laryngeal edema in patients with hereditary angioedema. , 2000, Mayo Clinic proceedings.
[24] H. McQuay,et al. The visual analogue pain intensity scale: what is moderate pain in millimetres? , 1997, PAIN.
[25] K. Todd,et al. Clinical significance of reported changes in pain severity. , 1996, Annals of emergency medicine.
[26] M. Cicardi,et al. Hereditary and Acquired C1‐Inhibitor Deficiency: Biological and Clinical Characteristics in 235 Patients , 1992, Medicine.
[27] B. Lämmle,et al. Detection and Quantitation of Cleaved and Uncleaved High Molecular Weight Kininogen in Plasma by Ligand Blotting with Radiolabeled Plasma Prekallikrein or Factor XI , 1988, Thrombosis and Haemostasis.
[28] B. Lämmle,et al. Detection of in vitro and in vivo cleavage of high molecular weight kininogen in human plasma by immunoblotting with monoclonal antibodies. , 1986, Blood.
[29] F. Rosen,et al. Genetically determined heterogeneity of the C1 esterase inhibitor in patients with hereditary angioneurotic edema. , 1971, The Journal of clinical investigation.